Leucettamine B
CAS No. 147395-96-8
Leucettamine B ( —— )
Catalog No. M12028 CAS No. 147395-96-8
Leucettamine B is a potent inhibitor of CLK1 (IC50=15 nM), Dyrk1A (IC50=40 nM), and Dyrk2 (IC50=35 nM) and a moderate inhibitor of CLK3 (IC50=4.5 uM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | Get Quote | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLeucettamine B
-
NoteResearch use only, not for human use.
-
Brief DescriptionLeucettamine B is a potent inhibitor of CLK1 (IC50=15 nM), Dyrk1A (IC50=40 nM), and Dyrk2 (IC50=35 nM) and a moderate inhibitor of CLK3 (IC50=4.5 uM).
-
DescriptionLeucettamine B is a potent inhibitor of CLK1 (IC50=15 nM), Dyrk1A (IC50=40 nM), and Dyrk2 (IC50=35 nM) and a moderate inhibitor of CLK3 (IC50=4.5 uM).
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetCLK
-
RecptorCLK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number147395-96-8
-
Formula Weight245.24
-
Molecular FormulaC12H11N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(5Z)-2-amino-5-(1,3-benzodioxol-5-ylmethylidene)-3-methylimidazol-4-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Chan GW, et al. J Nat Prod. 1993 Jan;56(1):116-21.
2. Debdab M, et al. J Med Chem. 2011 Jun 23;54(12):4172-86.
3. Tahtouh T, et al. J Med Chem. 2012 Nov 8;55(21):9312-30.
2. Debdab M, et al. J Med Chem. 2011 Jun 23;54(12):4172-86.
3. Tahtouh T, et al. J Med Chem. 2012 Nov 8;55(21):9312-30.
molnova catalog
related products
-
TG693
TG693 is an orally available, selective, ATP-competitive CLK1 inhibitor with IC50 of 112.6 nM.
-
K00546
K00546 is a potent inhibitor of the CDC2-like kinase CLK1 and CLK3 with IC50 of 8.9 and 29.2 nM, respectively.
-
ML167
A potent, selective CDC-like kinase 4 (CLK4) inhibitor with IC50 of 136 nM, >10-fold selectivity over Clk1, Clk2, Clk3, Dyrk1A/1B.